drugset / Trial / NCT00900237
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
RandomizedParallel-groupOpen-labelTreatment
Summary
This purpose of this study is to measure the concentrations of two anti-epileptic drugs (Eslicarbazepine acetate and oxcarbazepine) and their metabolites in the cerebrospinal fluid and blood plasma of healthy subjects and also to assess how these drugs are tolerated.
Timeline
- Start
- 2008-11
- Primary completion
- 2008-12
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eslicarbazepine acetate | Unknown | 1200 mg | Oral |
| Comparator | Oxcarbazepine | Small molecule | 600 mg | — |